Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Boderke
Peter Boderke, Schwalbach DE
| Patent application number | Description | Published |
|---|---|---|
| 20100144890 | USE OF A SURFACTANT FOR THE PREPARATION OF A FORMULATION FOR THE TREATMENT OF ADIPOSE DISEASES - Use of a mixture comprising at least one non-aromatic surfactant having a plurality of ether and/or ester groups and at least one carrier agent for the preparation of a formulation for the treatment of adipose tissue disease and/or condition with improved bioavailability and lipolysis behaviour. | 06-10-2010 |
| 20100197792 | 1-Amino-Alkylcyclohexane derivatives for the treatment of inflammatory skin diseases - The present invention relates to the treatment of an individual afflicted with inflammatory skin diseases comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative. | 08-05-2010 |
Peter Boderke, Frankfurt DE
| Patent application number | Description | Published |
|---|---|---|
| 20090275545 | Medicinal targeted local lipolysis - Aqueous phospholipid systems comprising at least one phospholipid, at least one bile acid and water are suitable for producing medicaments for the treatment of adipose tissue disorders and lead to regression of the pathologically proliferated adipose tissue. | 11-05-2009 |
| 20100004216 | Medicinal lipolysis of accumulation of fat - Aqueous preparations comprising at least one phospholipid or at least one bile acid and a component assisting degradation of fat such as riboflavin and water are suitable for producing medicaments for removing subcutaneous accumulations of fat and lead to regression of diet-resistant fat pads. | 01-07-2010 |
Peter Boderke, Frankfurt Am Main DE
| Patent application number | Description | Published |
|---|---|---|
| 20090186807 | Zinc-free and low-zinc insulin preparations having improved stability - The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations. | 07-23-2009 |